Comparison of the Sodium valproate and Sodae herbal capsule side effects in migraine patients

A comparative survey of the Sodium valproate and Sodae herbal capsule side effects in migraine patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200126046272N2

Enrollment

Registered

2020-05-14

Start date

2020-07-22

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine. Other disorders of nervous system

Interventions

Intervention 1: The intervention group will take 1 720 mg sodae capsule made by Boo Ali Daroo Company, with warm water every night before going to bed for three months. Intervention 2: The control gro

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Having more than 3 attacks per month in the last three months Having more than 3 attacks at the base time Start migraines at least one year before entering the project Start migraines before age 50

Exclusion criteria

Exclusion criteria: Chronic tension headaches or other headaches for more than 15 days a month Pregnancy, lactation Patients should not be addicted to alcohol or other illegal substances

Design outcomes

Primary

Measure	Time frame
Side effects. Timepoint: Baseline, Three months after the Baseline. Method of measurement: Record the side effects that the patient reports, Laboratory tests of people's blood samples.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNegin Fakhri

Kermanshah University of Medical Sciences

n.fakhri94@yahoo.com+98 83 3826 4447

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026